and cyclophosphamide on the incidence of hemolytic anemia fludarabine lymphocytic leukemia - a beneficial effect of the combination of The prognostic significance of a positive direct antiglobulin test in chronic

[1]  T Hamblin,et al.  Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial , 2007, The Lancet.

[2]  H. Kantarjian,et al.  Immune anaemias in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab – incidence and predictors , 2007, British journal of haematology.

[3]  M. Grever,et al.  Phase III trial of fludarabine plus cyclophosphamide compared with fludarabine for patients with previously untreated chronic lymphocytic leukemia: US Intergroup Trial E2997. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  F. Mandelli,et al.  Relationship between autoimmune phenomena and disease stage and therapy in B-cell chronic lymphocytic leukemia. , 2006, Haematologica.

[5]  G. Brittinger,et al.  Fludarabine plus cyclophosphamide versus fludarabine alone in first-line therapy of younger patients with chronic lymphocytic leukemia. , 2005, Blood.

[6]  R. Barker,et al.  Rh autoantigen presentation to helper T cells in chronic lymphocytic leukemia by malignant B cells. , 2005, Blood.

[7]  S. Schichman,et al.  Autoimmune cytopenia does not predict poor prognosis in chronic lymphocytic leukemia/small lymphocytic lymphoma † , 2003, American journal of hematology.

[8]  R. Foà,et al.  Autoimmune hemolytic anemia in chronic lymphocytic leukemia: clinical, therapeutic, and prognostic features. , 2000, Blood.

[9]  V. Leblond,et al.  Severe autoimmune hemolytic anemia in eight patients treated with fludarabine. , 1998, Hematology and cell therapy.

[10]  J. Byrd,et al.  Hemolytic anemia after fludarabine therapy for chronic lymphocytic leukemia. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  L. Diehl,et al.  Autoimmune disease and chronic lymphocytic leukemia: autoimmune hemolytic anemia, pure red cell aplasia, and autoimmune thrombocytopenia. , 1998, Seminars in oncology.

[12]  K. Maloum,et al.  Basic biology of autoimmune phenomena in chronic lymphocytic leukemia. , 1998, Seminars in oncology.

[13]  M. Błasińska-Morawiec,et al.  Autoimmune haemolytic anaemia in patients with chronic lymphocytic eukaemia treated with 2‐chlorodeoxyadenosine (cladribine) , 1997, European journal of haematology.

[14]  D. Oscier,et al.  Fludarabine‐related autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia , 1995, British journal of haematology.

[15]  J. Byrd,et al.  Fatal recurrence of autoimmune hemolytic anemia following pentostatin therapy in a patient with a history of fludarabine-associated hemolytic anemia. , 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

[16]  D. Oscier,et al.  Autoimmunity in chronic lymphocytic leukaemia. , 1986, Journal of clinical pathology.